Phase I trial for AG1343.
D000998:Antiviral Agents / Q000627:therapeutic use*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D066298:In Vitro Techniques; D019888:Nelfinavir
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D019888:Nelfinavir